Integrated BioPharma Q1 revenue down 6.6% to $12.7M; net income $0.1M, EPS $0.00

INTEGRATED BIOPHARMA INC

2026-Q1 EPS reported $0.00 revenue$12,689,000

Revenue $12.7M, down 6.6% from $13.6M YoY; gross profit $1.0M vs $1.4M.
Net income $123K ($0.00 basic EPS) vs $259K ($0.01) in prior year quarter.
Operating income $163K vs $490K YoY, driven by lower gross profit.
Two largest customers in Contract Manufacturing = 87% of total revenue (85% in prior year).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.